Literature DB >> 16980938

Pathogenesis of prion diseases: current status and future outlook.

Adriano Aguzzi1, Mathias Heikenwalder.   

Abstract

The prion, a conformational variant of a host protein, is the infectious particle responsible for transmissible spongiform encephalopathy (TSE), a fatal neurodegenerative disease of humans and animals. The principal target of prion pathology is the brain, yet most TSEs also display prion replication at extra-cerebral locations, including secondary lymphoid organs and sites of chronic inflammation. Despite significant progress in our understanding of this infectious agent, many fundamental questions relating to the nature of the prion, including the mechanism of replication and the molecular events underlying brain damage, remain unanswered. Here we focus on the unresolved issues pertaining to prion pathogenesis, particularly on the role played by the immune system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980938     DOI: 10.1038/nrmicro1492

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  69 in total

1.  Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia.

Authors:  Jiaxin Chang; Lifeng Yang; Mohammed Kouadir; Yun Peng; Siming Zhang; Fushan Shi; Xiangmei Zhou; Xiaomin Yin; Deming Zhao
Journal:  J Mol Neurosci       Date:  2012-05-31       Impact factor: 3.444

Review 2.  Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics.

Authors:  Anuradha Kalani; Alka Tyagi; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

3.  Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.

Authors:  Christopher J Choi; Vellareddy Anantharam; Dustin P Martin; Eric M Nicholson; Jürgen A Richt; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

Review 4.  Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.

Authors:  Peter K Stys; Haitao You; Gerald W Zamponi
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

5.  Hydration effects on the HET-s prion and amyloid-beta fibrillous aggregates, studied with three-dimensional molecular theory of solvation.

Authors:  Takeshi Yamazaki; Nikolay Blinov; David Wishart; Andriy Kovalenko
Journal:  Biophys J       Date:  2008-08-08       Impact factor: 4.033

Review 6.  A structural overview of the vertebrate prion proteins.

Authors:  Annalisa Pastore; Adriana Zagari
Journal:  Prion       Date:  2007-07-08       Impact factor: 3.931

7.  Mapping the interaction site of prion protein and Sho.

Authors:  Wan Jiayu; Hao Zhu; Xu Ming; Wang Xiong; Wu Songbo; Song Bocui; Liu Wensen; Li Jiping; Meng Keying; Li Zhongyi; Gao Hongwei
Journal:  Mol Biol Rep       Date:  2009-08-15       Impact factor: 2.316

8.  Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference.

Authors:  Sang-Gyun Kang; Yu-Mi Roh; Agnes Lau; David Westaway; Debbie McKenzie; Judd Aiken; Yong-Sun Kim; Han Sang Yoo
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

9.  Wound healing and the immune response in swine treated with a hemostatic bandage composed of salmon thrombin and fibrinogen.

Authors:  Stephen W Rothwell; Evelyn Sawyer; Jennifer Dorsey; William S Flournoy; Timothy Settle; David Simpson; Gary Cadd; Paul Janmey; Charles White; Kathleen A Szabo
Journal:  J Mater Sci Mater Med       Date:  2009-05-18       Impact factor: 3.896

10.  Paradoxical role of prion protein aggregates in redox-iron induced toxicity.

Authors:  Dola Das; Xiu Luo; Ajay Singh; Yaping Gu; Soumya Ghosh; Chinmay K Mukhopadhyay; Shu G Chen; Man-Sun Sy; Qingzhong Kong; Neena Singh
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.